The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Dechert LLP

ONE INTERNATIONAL PLACE, 40TH FLOOR, 100 OLIVER STREET, BOSTON, MA 02110-2605, USA
Tel:
Work +1 617 728 7100
Fax:
Fax +1 617 426 6567
Email:
Web:
www.dechert.com

Andrea L C Reid

Tel:
Work +1 617 728 7131
Email:
Dechert LLP

Work Department

Intellectual Property

Career

Andrea L.C. Reid, co-lead of Dechert’s Global Life Sciences Practice, counsels established and start-up clients in all sectors of the biotech and pharmaceutical industries on developing intellectual property issues, policies, patent portfolio management and filing strategies at all phases of the business cycle. Ms. Reid’s ability to develop IP strategies for U.S. and European clients has resulted in more than US$10 billion in acquisition and investor/partner funding. With more than 30 years of experience working in the pharmaceutical industry, she has extensive experience in all areas of drug discovery through drug development. She draws on this experience when prosecuting patent applications and preparing patentability, validity and infringement opinions involving active pharmaceutical ingredients, manufacturing syntheses and formulations. She regularly represents clients on specialty issues relating to organic chemistry, small molecule pharmaceuticals and polymorph intellectual property.

Education

Boston University, B.S., Chemistry, 1987 University of Massachusetts Lowell, M.S., Chemistry, 1996 Suffolk University Law School, J.D., Intellectual Property, 2006, with distinction


United States: Industry focus

Healthcare: life sciences

Within: Healthcare: life sciences

At Dechert LLP, the group is known for its expertise in patent litigation, as well as regulatory and transactional matters. In Philadelphia, George Gordon, who specializes in antitrust matters, has been defending Lannett Company against price-fixing claims, while Martin Black successfully represented Svenska Cellulosa (SCA) in a patent infringement dispute regarding the client’s hygiene product. Boston-based practice co-chair Andrea Reid assisted Nimbus Therapeutics with the development and implementation of a patent portfolio strategy regarding a program for patients with autoimmune disorders. The group is also led by New York-based David Rosenthal and also includes David Schulman in Washington DC.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to